Livestock Dewormers Market Size & Growth Forecast 2027–2036, By Segments (Mode, Animal Type, Drug Class, Distribution Channel, Route of Administration), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape
Market Size and Growth Outlook
Livestock Dewormers Market size was worth USD 8.56 Billion in 2026 and is poised to grow at 5.18% CAGR between 2027 and 2036, surpassing USD 14.18 Billion by 2036. The industry revenue for 2027 is assessed at USD 8.93 Billion.
Get more details on this report
Request Free Sample ReportLivestock Dewormers Market Intelligence Snapshot
Regional Market Dynamics
- North America led in 2026, supported by established livestock production, developed veterinary infrastructure, preventive animal healthcare awareness, and demand for effective parasite control.
- Asia Pacific is expanding fastest as livestock farming, animal-derived food demand, veterinary services, commercialization, and systematic herd health practices increase.
Segment Momentum
- OTC products held 64.99% of the market in 2026 because their widespread availability and convenience support routine preventive parasite management, allowing farmers to administer treatments quickly across commercial livestock operations.
- Poultry is projected to be the fastest-growing animal type as commercial poultry production expands and producers strengthen flock health, biosecurity, and parasite control practices to improve production efficiency.
Market Expansion Drivers
- Rising zoonotic disease prevalence increasing demand for preventive livestock parasite control
- Increasing livestock population driving higher demand for veterinary deworming treatments globally
- Precision veterinary diagnostics enabling targeted and optimized parasite treatment strategies
Leading Market Participants
- Major players in the livestock dewormers market include Zoetis Inc. (United States), Elanco Animal Health Incorporated (United States), Merck Animal Health (United States), Boehringer Ingelheim Animal Health (Germany), Virbac S.A. (France), Vetoquinol S.A. (France), Ceva Santé Animale (France), Dechra Pharmaceuticals PLC (United Kingdom), Phibro Animal Health Corporation (United States), Bimeda Holdings PLC (Ireland)
Global Market Forecast Snapshot
Market Outlook
- 2026 Market Size: USD 8.56 Billion
- 2027 Estimated Market Size: USD 8.93 Billion
- Projected Market Size: USD 14.18 Billion by 2036
- Growth Forecast: 5.18% CAGR (2027-2036)
Regional and Segment Outlook
- Leading Regional Market: North America
- High-Growth Regional Hub: Asia Pacific
- Core Revenue Segment: OTC (Mode) | Cattle (Animal Type) | Macrocyclic Lactones (Drug Class) | Veterinary Pharmacies (Distribution Channel) | Oral (Route of Administration)
- Emerging Opportunity Segment: Prescription (Mode) | Poultry (Animal Type) | Benzimidazoles (Drug Class) | Online Pharmacies (Distribution Channel) | Parenteral (Route of Administration)
Market Growth Drivers and Industry Trends
Rising zoonotic disease prevalence increasing demand for preventive livestock parasite control
Heightened awareness of diseases that can spread between animals and humans is encouraging stronger investments in preventive animal healthcare, and this development will drive the livestock dewormers market growth. Regular parasite control programs help reduce disease transmission risks while improving animal health, productivity, and overall herd management. Livestock producers are increasingly incorporating scheduled deworming practices into broader biosecurity strategies to maintain healthier animals and support safe food production systems.
Increasing livestock population driving higher demand for veterinary deworming treatments globally
The continued expansion of livestock farming is generating sustained demand for veterinary healthcare products, positioning the livestock dewormers market for increased adoption across commercial animal production systems. Larger cattle, sheep, goat, swine, and poultry populations require effective parasite management to maintain growth performance, reproductive health, and feed efficiency. Producers are investing in reliable deworming treatments that support healthier herds while reducing production losses associated with internal and external parasite infestations.
Precision veterinary diagnostics enabling targeted and optimized parasite treatment strategies
Advances in veterinary diagnostic technologies are transforming parasite management by enabling more informed treatment decisions, allowing the livestock dewormers market to benefit from increasingly targeted deworming strategies. Improved diagnostic tools help veterinarians and livestock producers identify parasite burdens with greater accuracy, reducing unnecessary treatment and supporting more effective medication use. Data-driven health management also contributes to optimized treatment schedules, improved herd monitoring, and better long-term parasite control across diverse livestock production environments.
| Growth Driver | Impact on CAGR | Regulatory Influence | Geographic Relevance | Adoption Rate | Impact Timeline |
|---|---|---|---|---|---|
| Rising zoonotic disease prevalence increasing demand for preventive livestock parasite control | 2% | High | Asia Pacific, Africa | High | Near Term |
| Increasing livestock population driving higher demand for veterinary deworming treatments globally | 1.5% | Moderate | Asia Pacific, Latin America | High | Mid Term |
| Precision veterinary diagnostics enabling targeted and optimized parasite treatment strategies | 1% | Moderate | Europe, North America | Emerging | Mid Term |
Unlock insights tailored to your business with our bespoke market research solutions.
Click to get your customized report now.
Regional Demand Dynamics
North America (Largest Region)
North America held the largest position in the livestock dewormers market in 2026, supported by a well-established livestock production sector and strong emphasis on animal health management. Extensive cattle, dairy, and other livestock operations create consistent demand for effective parasite control products, as parasitic infections can affect animal health, productivity, and overall farm efficiency. The region's developed veterinary healthcare infrastructure, greater awareness of preventive animal healthcare, and established distribution networks also facilitate the adoption of deworming treatments. In addition, producers are increasingly focused on maintaining herd health and reducing productivity losses, supporting sustained demand for livestock parasite management solutions.
Asia Pacific (Fastest-Growing Region)
Asia Pacific is expected to register the fastest growth in the market, driven by expanding livestock farming, rising demand for animal-derived food products, and growing awareness of livestock health. Increasing commercialization of farming operations is encouraging producers to adopt more systematic approaches to disease and parasite prevention. Improvements in veterinary services, animal healthcare accessibility, and farm management practices are further supporting the use of deworming products. Moreover, efforts to improve livestock productivity and maintain healthier herds are creating favorable conditions for market expansion across the region.
| Parameter | North America | Asia Pacific | Europe | Latin America | MEA |
|---|---|---|---|---|---|
| Innovation Hub i Scale Nascent Developing Advanced | |||||
| Cost-Sensitive Region i Scale Low Medium High | |||||
| Regulatory Environment i Scale Restrictive Neutral Supportive | |||||
| Demand Drivers i Scale Weak Moderate Strong | |||||
| Development Stage i Scale Emerging Developing Developed | |||||
| Adoption Rate i Scale Low Medium High | |||||
| New Entrants / Startups i Scale Sparse Moderate Dense | |||||
| Macro Indicators i Scale Weak Stable Strong |
Key Country Insights
United States 🇺🇸
Herd Health ManagementThe U.S. livestock dewormers market emphasizes preventive herd health strategies across large-scale cattle, swine, and sheep operations. Producers in the U.S. increasingly adopt targeted parasite control programs supported by veterinary guidance and responsible product rotation practices.
Germany 🇩🇪
Sustainable Parasite ControlGermany promotes livestock dewormers that align with animal welfare standards and responsible veterinary medicine practices. German producers focus on effective parasite management while supporting sustainable livestock production and careful treatment planning.
Japan 🇯🇵
Precision Livestock CareJapan prioritizes livestock dewormers that support efficient animal health management within intensive farming systems. Farmers in Japan increasingly use targeted treatment approaches that improve productivity while maintaining high standards of livestock care.
South Korea 🇰🇷
Biosecurity-Driven TreatmentSouth Korea integrates livestock dewormers into broader animal health and farm biosecurity programs. Producers in South Korea emphasize timely parasite management to maintain livestock productivity and reduce health-related production disruptions.
France 🇫🇷
Veterinary Stewardship FocusFrance maintains demand for livestock dewormers through structured veterinary oversight and responsible animal health practices. French livestock producers increasingly adopt selective treatment programs that balance effective parasite control with sustainable farm management objectives.
Italy 🇮🇹
Farm Productivity SupportItaly uses livestock dewormers to improve herd performance across diverse livestock production systems. Italian farmers prioritize practical parasite management strategies that support animal well-being, consistent productivity, and efficient veterinary care throughout production cycles.
Segment Leadership and Growth Trends
Livestock Dewormers Market Share (%), by Mode, 2026
Go beyond the chart, access full insights & data tables
Request Free Sample ReportMode Segment Analysis: OTC (Largest Segment) vs Prescription (Fastest-Growing Segment)
The OTC mode dominated the livestock dewormers market, accounting for 64.99% of the market share in 2026. Its leadership is driven by the widespread availability of over-the-counter deworming products and their convenience for routine parasite management in livestock operations. Farmers and livestock owners often prefer OTC products for regular preventive treatment because they offer easier access and enable timely administration without additional procedural requirements, supporting broad adoption across commercial farming activities.
The prescription mode is expected to experience the fastest growth as livestock producers place greater emphasis on targeted parasite control and responsible use of veterinary medicines. Increasing awareness of parasite resistance, the need for accurate diagnosis, and growing veterinary oversight are encouraging greater adoption of prescription-based treatments. This trend is also supported by the rising focus on improving animal health outcomes and optimizing treatment effectiveness.
Animal Type Segment Analysis: Cattle (Largest Segment) vs Poultry (Fastest-Growing Segment)
Cattle accounted for the largest share of 48.34% in 2026, reflecting the high economic importance of cattle farming and the significant need for effective parasite management to maintain productivity and animal health. Regular deworming programs are widely implemented to improve weight gain, milk production, and reproductive performance, making cattle the leading animal type within the market. The large global cattle population and the emphasis on preventive healthcare continue to reinforce this segment's dominance.
Within the livestock dewormers market, the poultry segment is anticipated to grow at the fastest pace due to the rapid expansion of commercial poultry production and increasing attention to flock health management. Rising demand for high-quality poultry products is encouraging producers to adopt comprehensive disease and parasite control practices. Greater awareness of biosecurity measures and the importance of maintaining production efficiency are further contributing to the growth of this segment.
Drug Class Segment Analysis: Macrocyclic Lactones (Largest Segment) vs Benzimidazoles (Fastest-Growing Segment)
Macrocyclic lactones held the largest market share of 43.46% in 2026, supported by their broad-spectrum effectiveness against both internal and external parasites. Their widespread use across multiple livestock species, combined with convenient administration options and proven efficacy, has made them a preferred choice in routine parasite management programs. Continued reliance on these products for maintaining animal health and productivity has sustained their leading market position.
The benzimidazole drug class is expected to witness the fastest growth in the livestock dewormers market as livestock producers increasingly adopt diversified parasite control strategies to address evolving treatment requirements. Growing attention to rotational deworming practices and the need for effective management of specific parasite species are supporting demand for benzimidazole-based products. Ongoing improvements in livestock healthcare practices are also expected to contribute to the expansion of this segment.
| Segment | Sub-Segment | Largest Segment | Fastest Growing |
|---|---|---|---|
| Mode | OTC, Prescription | OTC | Prescription |
| Animal Type | Cattle, Swine, Poultry, Others | Cattle | Poultry |
| Drug Class | Benzimidazoles, Macrocyclic Lactones, Imidazothiazoles, Others | Macrocyclic Lactones | Benzimidazoles |
| Distribution Channel | Veterinary Pharmacies, Retail Pharmacies, Online Pharmacies | Veterinary Pharmacies | Online Pharmacies |
| Route of Administration | Oral, Topical, Parenteral | Oral | Parenteral |
Competitive Landscape and Market Positioning
Leading companies in the livestock dewormers market:
- Zoetis, Inc. (United States)
- Elanco Animal Health Incorporated (United States)
- Merck Animal Health (United States)
- Boehringer Ingelheim Animal Health (Germany)
- Virbac S.A. (France)
- Vetoquinol S.A. (France)
- Ceva Santé Animale (France)
- Dechra Pharmaceuticals PLC (United Kingdom)
- Phibro Animal Health Corporation (United States)
- Bimeda Holdings PLC (Ireland)
Shifting livestock health priorities are changing the basis of competition in the Livestock Dewormers Market, with sustained parasite control strategies becoming more influential than the sale of individual treatment products. Manufacturers are placing greater emphasis on formulations that support responsible resistance management, broader species applicability, and practical administration across diverse production systems. At the same time, veterinary guidance and herd health planning are playing a larger role in purchasing decisions, encouraging suppliers to complement product portfolios with technical expertise and disease management support. This evolution is rewarding participants that can align treatment efficacy with long-term animal health outcomes while adapting to changing regulatory expectations surrounding veterinary pharmaceuticals.
| Company | Market Share | Company Revenue | Revenue CAGR (%) | Product Portfolio | Geographic Presence | Innovation / R&D Focus | Strategic Developments |
|---|---|---|---|---|---|---|---|
| Zoetis Inc. (United States) | |||||||
| Elanco Animal Health Incorporated (United States) | |||||||
| Merck Animal Health (United States) | |||||||
| Boehringer Ingelheim Animal Health (Germany) | |||||||
| Virbac S.A. (France) | |||||||
| Vetoquinol S.A. (France) | |||||||
| Ceva Santé Animale (France) | |||||||
| Dechra Pharmaceuticals PLC (United Kingdom) | |||||||
| Phibro Animal Health Corporation (United States) | |||||||
| Bimeda Holdings PLC (Ireland) |
Industry Development/News
| Company Name | Date | Key Development |
|---|---|---|
| Merck Animal Health | Nov-24 | Merck Animal Health received U.S. FDA approval for Safe-Guard Aquasol as the first approved chicken dewormer for backyard flocks, enhancing its product portfolio and expanding market reach within the poultry sector. |
| Zoetis | Jul-23 | Zoetis launched Valcor, an injectable combination endectocide for cattle in the U.S., integrating doramectin and levamisole to address internal and external parasite management challenges in beef and dairy operations. |
| Ceva Animal Health | Jun-21 | Ceva Animal Health announced a legal category reclassification for Eprecis, its zero-milk withdrawal injectable wormer for cows, designed to increase veterinarian involvement and direct impact on farm parasite control strategies. |
Customize Your Report
Explore examples of how this report can be tailored to different research needs, including custom segments, additional topics or chapters, and related reports. Click a section of the wheel or its numbered marker to explore the available options.
Livestock Dewormers Market — Custom Segments
| Segment | Sub-Segment |
|---|---|
| Parasite Target | Gastrointestinal Nematodes, Lungworms, Tapeworms, Liver Flukes, External Parasites |
| Livestock Production System | Intensive/Industrial Farming, Semi-Intensive Farming, Extensive/Pasture-Based Farming |
| Farm Size | Small Farms, Medium Farms, Large Commercial Farms, Industrial-Scale Operations |
Livestock Dewormers Market — Custom TOC
| Custom Chapter | Custom Details |
|---|---|
| Veterinary Anthelmintic Resistance & Control Strategy |
|
| Livestock Parasite Control Economics |
|
| Deworming Program Adoption & Treatment Practices |
|
Need a different cut of the data?
Request Custom ResearchWhat is the current size of the livestock dewormers market?
How is the livestock dewormers industry size expected to evolve during the forecast period?
What factors are driving adoption of preventive deworming programs in livestock production?
How are precision diagnostics transforming parasite management in the livestock dewormers market?
Why does the OTC mode lead the livestock dewormers market?
Which animal type is expected to grow the fastest in the livestock dewormers market?
What supports North America's leadership in the livestock dewormers market?
Why is Asia Pacific expected to grow fastest in livestock dewormers?
Who are the leading players in the livestock dewormers landscape?
Our Clients
"The team took the time to understand our specific business needs and delivered a report that was well aligned with our objectives. Their expertise and understanding of the industry were clearly reflected in the quality and relevance of the insights provided."
Siemens Healthcare
"Our experience in acquiring the research report has been excellent. The depth of analysis, and actionable insights provided have been extremely valuable in supporting our ongoing R&D efforts."
GC Biopharma
"The report offered a comprehensive view of the market trends. The in-depth segmentation and analysis of emerging opportunities gave us a better understanding of the market."
Medtronic
Our Research Team & Methodology
Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.
Research Team Overview
Prepared by the Healthcare & Medical Devices Research Team
Delivery
Published
Demand
Available
Support
Trust & Compliance
Research Intelligence
Research Workflow & Quality Assurance
Data Collection
Verified information gathered through primary and secondary research.
Data Triangulation
Cross-validation using multiple independent data sources.
Forecast Modelling
Market estimates developed using historical trends and analytical models.
Analyst Validation
Findings reviewed by domain experts for accuracy and consistency.
Editorial & Quality Review
Final editorial, quality, and compliance checks before publication.
Final Publication
Released after successful completion of the internal review process.
Report Coverage
📊 Market Assessment
- Market Size & Forecast
- Market Segmentation
- Regional Analysis
- Growth Drivers & Challenges
- Market Dynamics
🏢 Competitive Intelligence
- Competitive Landscape
- Company Profiles
- Competitive Benchmarking
- Mergers & Acquisitions
- Market Share Analysis or Key Company Strategies
🔍 Strategic Analysis
- Value Chain Analysis
- Porter's Five Forces
- PESTLE Analysis
- Pricing Trends
- Supply-Demand Analysis
🚀 Future Outlook
- Technology Landscape
- Regulatory Landscape
- Investment & Funding Landscape
- Emerging Opportunities
- Future Market Outlook
Have a question about this report or need a custom scope?
Request Customization